B2Gold stock price rises on Friday as gold flirts with $5,000; Feb. 18 earnings are next
25 January 2026
1 min read

B2Gold stock price rises on Friday as gold flirts with $5,000; Feb. 18 earnings are next

New York, Jan 25, 2026, 06:32 (ET) — Market closed

B2Gold Corp (BTG) shares closed Friday on an upnote, riding the wave alongside a broad rally in gold miners.

The U.S.-listed stock ticked up roughly 1.6% to $5.29, bouncing between $5.16 and $5.38 on around 47.0 million shares. The VanEck Gold Miners ETF (GDX) jumped about 1.8%, with Newmont (NEM) gaining roughly 2.2%, and Kinross Gold (KGC) edging up about 1.4%.

U.S. markets are closed for the weekend, leaving Monday’s key question: can bullion hold steady and keep miners supported?

B2Gold’s immediate play is straightforward: gold prices drive daily moves, but it’s the guidance that will steer the story for weeks.

Gold climbed to a new high near $5,000 an ounce on Friday, fueled by safe-haven buying and bets on U.S. rate cuts. Spot gold last gained 0.6% to $4,964.81 after earlier reaching $4,988.17. “Gold’s role as a haven and a diversifier … is making it a necessity for strategic portfolios,” said Tai Wong, an independent metals trader. 1

A Form 6-K filing revealed B2Gold plans to report its fourth-quarter and full-year 2025 results, plus 2026 outlook, after North American markets close on Feb. 18. The company’s executives will go over the numbers during a conference call the next day, Feb. 19, at 11:00 a.m. ET, the filing noted. 2

Timing is crucial since miners’ valuations can swing quickly as metal prices surge, making guidance the key reference point.

Investors usually zero in on production targets and costs, particularly all-in sustaining costs, or AISC — a per-ounce figure covering the ongoing expenses required to keep a mine operational.

Based in Vancouver, B2Gold runs mines in Canada, Mali, Namibia, and the Philippines, exposing the company to diverse cost structures and operating environments.

If gold prices remain high, investors will push the company to prove it can turn that environment into consistent free cash flow, rather than merely boosting revenue.

The downside scenario is well-known. A steep drop in gold prices, rising input costs, or a hiccup in operations could wipe out any metal-fueled gains just as fast. Plus, rallies with heavy volume often trigger swift profit-taking.

Miners will look to bullion for direction once trading picks up Monday. BTG’s next major event is on Feb. 18, when it’s set to release its results along with the 2026 outlook. 3

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Applied Digital (APLD) stock jumps on 430MW “AI factory” build — what to watch before Monday
Previous Story

Applied Digital (APLD) stock jumps on 430MW “AI factory” build — what to watch before Monday

Critical Metals (CRML) stock price jumps 12% as big holder sells shares — what to watch Monday
Next Story

Critical Metals (CRML) stock price jumps 12% as big holder sells shares — what to watch Monday

Go toTop